Attributable cost of methicillin resistance: an issue that is difficult to evaluate
-
Correspondence: Jean-François Timsit jftimsit@chu-grenoble.fr
Groupe d'épidémiologie des cancers et des affections graves INSERM U 578, Service de réanimation médicale, University Hospital Albert Michallon, 38043 Grenoble Cedex, France
Critical Care 2006, 10:157 doi:10.1186/cc4994
Published: 11 August 2006Abstract
Estimating the consequences and the cost of methicillin resistance is a difficult challenge. Patients who develop methicillin-resistant ventilator-associated pneumonia (VAP) are very different from those who develop methicillin-sensitive VAP, and biased estimates are frequent. We reviewed some important confounding factors of which the reader should be aware.